Home Pharmaceuticals PharmaVoice’s Crystal Ball: What’s next for AI and drug R&D

PharmaVoice’s Crystal Ball: What’s next for AI and drug R&D

by Newsroom


This audio is auto-generated. Please let us know if you have feedback.

This is the second installment of our two-part series examining pharma’s year ahead. Our first installment looked at industry predictions for the biotech market and regulations.

As AI finds solid footing in pharma R&D, the technology is slated to yield significant rewards. 

Industry leaders expect that up to 30%…



Source link

You may also like

About Us

Health-Newswire.Net™ aggregates, publishes and distributed news about the Healthcare industry. In association with EmailWire, Health-Newswire.Net™ provides press release distribution services in the Healthcare sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Health Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC